GlassScriptPhysician profile
Vanmaly P Sangasy
NPI 1265065551
$5,834.30
in general payments reported to CMS, 2019-2025
34 companies · $1,121 in 2025
The $1,121 reported for 2025 was more than what 86% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,775 · 2022: $268 · 2023: $864 · 2024: $806 · 2025: $1,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,738 · Education: $54.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,737.69 |
| Education | $54.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $829.42 | 2021-2025 | Camzyos, Sotyktu, Eliquis |
| Amgen INC. | $623.34 | 2021-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $547.78 | 2021-2025 | Jardiance |
| Lilly USA, LLC | $382.93 | 2021-2025 | Jardiance, Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $353.08 | 2021-2024 | Wainua |
| Abbvie INC. | $352.32 | 2021-2022 | |
| Pfizer INC. | $329.06 | 2023-2025 | |
| Novo Nordisk INC | $306.55 | 2021-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $273.29 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $209.48 | 2024-2025 | Uptravi, Opsumit |
| Otsuka America Pharmaceutical, INC. | $171.20 | 2021 | |
| Novartis Pharmaceuticals Corporation | $137.90 | 2023-2025 | |
| Glaxosmithkline, LLC. | $132.12 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $130.50 | 2021 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $104.89 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $90.07 | 2021 | |
| Gilead Sciences, INC. | $79.00 | 2021 | |
| Currax Pharmaceuticals LLC | $76.99 | 2021 | |
| Amarin Pharma, INC. | $70.70 | 2021 | |
| Merck Sharp & Dohme LLC | $64.91 | 2021 | |
| Eisai INC. | $62.91 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.29 | 2021 | |
| Medtronic, INC. | $54.00 | 2023 | |
| Scpharmaceuticals INC. | $38.50 | 2025 | |
| Bridgebio Pharma, INC. | $34.95 | 2025 | Attruby |
| Baxter Healthcare | $33.45 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Esperion Therapeutics, INC. | $31.01 | 2024 | Nexletol |
| Kiniksa Pharmaceuticals International, Plc | $27.46 | 2024 | Arcalyst |
| Genentech USA, INC. | $23.33 | 2021 | |
| Corcept Therapeutics | $23.16 | 2021 | |
| Incyte Corporation | $20.34 | 2025 | Jakafi |
| Astellas Pharma US INC | $18.77 | 2021 | |
| Avanir Pharmaceuticals, INC. | $14.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanmaly Sangasy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.